VANCOUVER, BRITISH COLUMBIA--(Marketwire - Sept. 24, 2012) - EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave" or "the Company") announced today that the Company has received a favorable review from the Patent Cooperation Treaty ("PCT") Examiner for its powderREV™ III patent application, which includes a novel recycling system. The design provides the EnWave with the ability to dehydrate enzymes, probiotics and biopharmaceuticals in a more efficient manner either continuously or in batch amounts. This flexibility aligns well with the industry's current processing best practices.
The views expressed by the PCT Examiner are not binding on examiners in any patent office. However, they are a guide to whether national patent offices are likely to raise significant objections to granting patents having claims like those pending in the PCT application. The examiner indicated that all three requirements for patentability, namely, novelty, inventive step and industrial applicability, are satisfied by all the claims submitted in EnWave's application.
"Over the past year, EnWave has received strong interest from pharmaceutical, enzyme and probiotic companies," stated Dr. Tim Durance, Chairman and Co-CEO, EnWave Corporation. "The ability to provide a flexible platform for their dehydration needs is of paramount importance as each material requires specific processing parameters."
EnWave holds an expanding intellectual property portfolio designed to protect its technology and knowledge base. The Company's patented technology combines microwave energy with vacuum pressure to control the temperature at which liquids boil and subsequently evaporate. This form of liquid evaporation is a major advancement in the dehydration of food and biological materials. REV technology is currently being developed to replace freeze drying and compete directly with spray and air drying.
EnWave Corporation is a Vancouver-based industrial technology company developing commercial applications for its proprietary Radiant Energy Vacuum (REV) dehydration technology. The company recently licensed REV technology to Milne Fruit Products Inc, its first major U.S. customer, to support a launch of healthy berry snacks and powders across most major markets in North America. More recently, EnWave licensed REV technology to one of its Tier 1 multinational partners from the list below. In addition, EnWave has entered a wide range of research and collaboration agreements with an expanding list of multinational partners, including Nestlé, Kellogg's, Grupo Bimbo, Grimmway Farms, Ocean Spray Cranberries, Hormel, Bonduelle, Cherry Central, Sun-Maid Growers and Merck. EnWave is introducing REV as a new dehydration standard in the food and biological material sectors: potentially faster and cheaper than freeze drying, with better end product quality than air drying or spray drying.
EnWave currently has six REV platforms: commercial-scale nutraREV® and MIVAP® are used in the food industry to dry fruits, vegetables, meat, herbs and seafood quickly and at low-cost, while maintaining high levels of nutrition, taste, texture and colour. The Company is also developing powderREV™ for bulk dehydration of food cultures, probiotics and fine biochemicals such as enzymes; quantaREV™ for continuous, high-volume low-temperature drying of pastes, gels, liquids, or particulates; and bioREV™ and freezeREV™ as new methods to stabilize and dehydrate biopharmaceuticals such as vaccines and antibodies. More information about EnWave is available at www.enwave.net.
Dr. Tim Durance, Chairman & Co-CEO
Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. There is no guarantee that the Company's REV technology can or will improve processes in the target industry; even if the Company's REV technology can be used as described in this document, there is no guarantee that such use will result in orders for the Company's REV technology. All figures comparing REV technologies to freeze drying or other dehydration technologies are provided as examples of data obtained through the Company's own scientific and testing programs; each product must be tested individually to determine the benefits of using REV.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.